Himangshu Deka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Himangshu Deka has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ananta Choudhury
Faculty of Pharmaceutical Science, Assam Down Town University, Guwahati, India
4 shared publications - Arindam Chakraborty
Saankhya Labs Pvt. Ltd, Bangalore, India
1 shared publication - Biplab Kumar Dey
Faculty of Pharmaceutical Science, Assam Down Town University, Guwahati, Assam, India
1 shared publication - Debasmita Ghosh1 shared publication
- Debgopal Ganguly1 shared publication
Dhiraj Baishya
Faculty of Pharmaceutical Science Assam down town university, Sankar Madhab Path, Gandhinagar, Panikhaiti, Guwahati, Assam 781026, India
1 shared publication
Latest Publications
- Open Access
- 30 June 2026
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 29 (2) , 162-173
Comprehensive Chemical Profiling and Assessment of In-Vitro Antioxidant and Antidiabetic Activities of Polysaccharides Derived from Allium cepa and Allium sativum
Polysaccharides from diverse plant species have been consumed since ancient times to meet human energy needs. In recent years, plant-derived polysaccharides have gained scientific interest for their potential medicinal properties. Multiple studies indicate that these compounds exhibit a wide range of pharmacological activities. This study evaluated the antioxidant and antidiabetic properties of polysaccharides extracted from Allium sativum (ASP) and Allium cepa (ACP). Polysaccharides were isolated by hot-water extraction followed by ethanol precipitation. The extracts were chemically characterized through phytochemical tests and FT-IR analysis. Antioxidant and antidiabetic activities were assessed using DPPH radical scavenging, α-glucosidase and α-amylase inhibition assays, and an in vitro glucose uptake assay. Polysaccharides from both species were pale yellow in color. Total carbohydrate content was 76.12% for ASP and 72.93% for ACP. FT-IR analysis indicated the presence of reducing sugars and pectic polysaccharides. ASP showed stronger DPPH radical scavenging activity (IC50 = 85.7 ± 1.06 μg/mL) than ACP (IC50 = 99.38 ± 1.39 μg/mL), though both were less potent than ascorbic acid. ASP also demonstrated greater α-amylase inhibition (IC50 = 61.57 ± 0.86 μg/mL) compared with ACP (IC50 = 72.82 ± 2.51 μg/mL). α-Glucosidase inhibition was similar between ASP (IC50 = 69.56 ± 1.31 μg/mL) and ACP (IC50 = 68.61 ± 2.09 μg/mL). Both extracts enhanced glucose utilization in a dose-dependent manner, with ASP showing the highest glucose stimulation at 758.3 μg/mL, significantly increasing glucose uptake relative to untreated controls. Polysaccharides from Allium species exhibit promising potential to be used in diabetes therapy. Further in vivo studies and clinical trials are required to confirm these findings.
- 30 June 2026
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 29 (2) , 162-173
Open AccessComprehensive Chemical Profiling and Assessment of In-Vitro Antioxidant and Antidiabetic Activities of Polysaccharides Derived from Allium cepa and Allium sativum
Polysaccharides from diverse plant species have been consumed since ancient times to meet human energy needs. In recent years, plant-derived polysaccharides have gained scientific interest for their potential medicinal properties. Multiple studies indicate that these compounds exhibit a wide range of pharmacological activities. This study evaluated the antioxidant and antidiabetic properties of polysaccharides extracted from Allium sativum (ASP) and Allium cepa (ACP). Polysaccharides were isolated by hot-water extraction followed by ethanol precipitation. The extracts were chemically characterized through phytochemical tests and FT-IR analysis. Antioxidant and antidiabetic activities were assessed using DPPH radical scavenging, α-glucosidase and α-amylase inhibition assays, and an in vitro glucose uptake assay. Polysaccharides from both species were pale yellow in color. Total carbohydrate content was 76.12% for ASP and 72.93% for ACP. FT-IR analysis indicated the presence of reducing sugars and pectic polysaccharides. ASP showed stronger DPPH radical scavenging activity (IC50 = 85.7 ± 1.06 μg/mL) than ACP (IC50 = 99.38 ± 1.39 μg/mL), though both were less potent than ascorbic acid. ASP also demonstrated greater α-amylase inhibition (IC50 = 61.57 ± 0.86 μg/mL) compared with ACP (IC50 = 72.82 ± 2.51 μg/mL). α-Glucosidase inhibition was similar between ASP (IC50 = 69.56 ± 1.31 μg/mL) and ACP (IC50 = 68.61 ± 2.09 μg/mL). Both extracts enhanced glucose utilization in a dose-dependent manner, with ASP showing the highest glucose stimulation at 758.3 μg/mL, significantly increasing glucose uptake relative to untreated controls. Polysaccharides from Allium species exhibit promising potential to be used in diabetes therapy. Further in vivo studies and clinical trials are required to confirm these findings.
- Open Access
- 25 April 2026
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 817-837
Phytochemical Composition and Antimicrobial Activities of Edible Fruits from Assam, India: A Review of Bioactive Constituents and Experimental Evidence
In today’s world, antimicrobial resistance has emerged as a critical health concern that is fueling the hunt for natural alternative medicinal agents. Wild edible fruits contain a variety of phytochemicals and have promising antibacterial properties that could slow the emergence of resistance. This review compiles the most recent information on the phytochemical composition and antibacterial qualities of edible fruits that are indigenous to or frequently found in Assam, India. According to recent studies, bioactive phytochemicals such as flavonoids, phenolic acids, tannins, alkaloids, terpenoids, and organic acids can be found in fruits, including Citrus limon, Citrus jambhiri, Mangifera indica, Psidium guajava, Musa paradisiaca, and Punica granatum. By interfering with the production of biofilms, disrupting cell membranes, and inhibiting enzyme systems, these components demonstrate broad-spectrum antibacterial efficacy against harmful bacteria and fungi. Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans are all significantly inhibited by a number of in vitro investigations on fruit extracts, juices, and peel fractions. Overall, the edible fruits of Assam are a significant source of natural antimicrobial compounds, highlighting their potential for use in creating sustainable, cost-effective, and safe methods of battling antibiotic resistance. Major Findings: Assam wild fruits contain various bioactive phytochemicals such as flavonoids, phenolics, and tannins with notable antimicrobial activities. The extracts of the edible fruits of Assam exhibit bacteriostatic properties against selected pathogenic bacteria and fungi, showing their potential as natural alternatives for antimicrobial agents and functional food applications.
- 25 April 2026
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 817-837
Open AccessPhytochemical Composition and Antimicrobial Activities of Edible Fruits from Assam, India: A Review of Bioactive Constituents and Experimental Evidence
In today’s world, antimicrobial resistance has emerged as a critical health concern that is fueling the hunt for natural alternative medicinal agents. Wild edible fruits contain a variety of phytochemicals and have promising antibacterial properties that could slow the emergence of resistance. This review compiles the most recent information on the phytochemical composition and antibacterial qualities of edible fruits that are indigenous to or frequently found in Assam, India. According to recent studies, bioactive phytochemicals such as flavonoids, phenolic acids, tannins, alkaloids, terpenoids, and organic acids can be found in fruits, including Citrus limon, Citrus jambhiri, Mangifera indica, Psidium guajava, Musa paradisiaca, and Punica granatum. By interfering with the production of biofilms, disrupting cell membranes, and inhibiting enzyme systems, these components demonstrate broad-spectrum antibacterial efficacy against harmful bacteria and fungi. Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans are all significantly inhibited by a number of in vitro investigations on fruit extracts, juices, and peel fractions. Overall, the edible fruits of Assam are a significant source of natural antimicrobial compounds, highlighting their potential for use in creating sustainable, cost-effective, and safe methods of battling antibiotic resistance. Major Findings: Assam wild fruits contain various bioactive phytochemicals such as flavonoids, phenolics, and tannins with notable antimicrobial activities. The extracts of the edible fruits of Assam exhibit bacteriostatic properties against selected pathogenic bacteria and fungi, showing their potential as natural alternatives for antimicrobial agents and functional food applications.
- Open Access
- 31 October 2024
- Published by Creative Pharma Assent in Journal of Applied Pharmaceutical Research
- Vol. 12 (5) , 16-27
Comprehensive review of breast cancer risk factors, diagnosis, screening, and treatment methods
Background: Breast cancer is one of the leading causes of cancer-related deaths among women, accounting for 11.7% of all cancer cases and approximately 685,000 deaths worldwide in 2020. Its multifactorial etiology includes genetic, hormonal, and lifestyle-related risk factors with significant implications for diagnosis and treatment. Understanding these factors and the latest advancements in screening and therapeutic approaches is essential for improving patient outcomes. Methodology: This review synthesizes findings from peer-reviewed articles, clinical trials, and meta-analyses. The focus is on identifying key risk factors for breast cancer, evaluating the effectiveness of current diagnostic methods, and examining the latest treatment strategies, including personalized medicine. Data were collected from PubMed, Scopus, and Google Scholar databases. Results and Discussion: The review highlights major risk factors, including BRCA1/BRCA2 mutations, which contribute to a 45-65% lifetime risk, as well as hormonal influences and lifestyle factors like obesity and alcohol consumption. Targeted therapies, such as HER2 inhibitors (e.g., trastuzumab) and hormone therapies (e.g., tamoxifen), have significantly improved survival rates. Emerging treatments like immunotherapy and PARP inhibitors are also promising for aggressive and metastatic cases. Conclusion: Breast cancer continues to pose a significant health challenge, but advancements in risk assessment, early detection, and personalized treatment offer hope for better outcomes. Continued research and refining diagnostic and therapeutic approaches are essential for reducing breast cancer mortality and enhancing patient quality of life.
- 31 October 2024
- Published by Creative Pharma Assent in Journal of Applied Pharmaceutical Research
- Vol. 12 (5) , 16-27
Open AccessComprehensive review of breast cancer risk factors, diagnosis, screening, and treatment methods
Background: Breast cancer is one of the leading causes of cancer-related deaths among women, accounting for 11.7% of all cancer cases and approximately 685,000 deaths worldwide in 2020. Its multifactorial etiology includes genetic, hormonal, and lifestyle-related risk factors with significant implications for diagnosis and treatment. Understanding these factors and the latest advancements in screening and therapeutic approaches is essential for improving patient outcomes. Methodology: This review synthesizes findings from peer-reviewed articles, clinical trials, and meta-analyses. The focus is on identifying key risk factors for breast cancer, evaluating the effectiveness of current diagnostic methods, and examining the latest treatment strategies, including personalized medicine. Data were collected from PubMed, Scopus, and Google Scholar databases. Results and Discussion: The review highlights major risk factors, including BRCA1/BRCA2 mutations, which contribute to a 45-65% lifetime risk, as well as hormonal influences and lifestyle factors like obesity and alcohol consumption. Targeted therapies, such as HER2 inhibitors (e.g., trastuzumab) and hormone therapies (e.g., tamoxifen), have significantly improved survival rates. Emerging treatments like immunotherapy and PARP inhibitors are also promising for aggressive and metastatic cases. Conclusion: Breast cancer continues to pose a significant health challenge, but advancements in risk assessment, early detection, and personalized treatment offer hope for better outcomes. Continued research and refining diagnostic and therapeutic approaches are essential for reducing breast cancer mortality and enhancing patient quality of life.
- Open Access
- 30 September 2022
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 25 (3) , 199-208
An Overview on Plant Derived Phenolic Compounds and Their Role in Treatment and Management of Diabetes
Himangshu Deka, Ananta Choudhury*, Biplab Kumar Dey. J Pharmacopuncture 2022;25:199-208. https://doi.org/10.3831/KPI.2022.25.3.199
- 30 September 2022
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 25 (3) , 199-208
Open AccessAn Overview on Plant Derived Phenolic Compounds and Their Role in Treatment and Management of Diabetes
Himangshu Deka, Ananta Choudhury*, Biplab Kumar Dey. J Pharmacopuncture 2022;25:199-208. https://doi.org/10.3831/KPI.2022.25.3.199